22C-10-5 Differences in toxic changes between CB6F1-Tg-rasH2 mice and their nontransgenic littermates given cyclophosphamide by gavage weekly for 5 or 26 weeks (2) Immunotoxicity.

スポンサーリンク

概要

著者

関連論文

Collaborative work on evaluation of ovarian toxicity by repeated-dose and fertility studies in female rats
Morphological characterization of the ovary under normal cycling in rats and its viewpoints of ovarian toxicity detection
W1-2 ICH Survey on Immunotoxicity Data(WORKSHOP 1: CURRENT OF ICH GUIDANCE ON IMMUNOTOXICITY TEST)(Proceedings of the 31st Annual Meeting)
PD1-2 Role of histopathology in immunotoxicity evaluation(PANEL DISCUSSION 1: RECENT STATUS AND FUTURE PERSPECTIVES OF IMMUNOTOXICOLOGY)(Proceedings of the 31st Annual Meeting)
Relationship between the accumulation of p53 protein and the level of DNA damage induced by ENNG and mitomycin C in human hepatoma HepG2 cells(Mutagenicity, Carcinogenicity, Proceedings of the 32nd Annual Meeting)
O-21 An investigation of a possible method of genotoxic screening using RT-PCR analysis of p53-regulated genes(MUTAGENICITY)(GENERAL SESSION BY ORAL PRESENTATION)(Proceedings of the 31st Annual Meeting)
Genotoxicity screening on an early phase of drug development using Ames miniscreen assay and in vitro micronucreus test (MUTAGENICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
Carcinogenic comparative study on rasH2 mice produced by two breeding facilities
Complete parallelism between enhancement of dopamine β -hydroxylase activity and increase in the rate of cell proliferation in adrenal medulla of male rats after reserpine treatment.
Progesterone and medroxyprogesterone acetate accelerate the chronic nephropathy in female F344 rats
EXAMINATION OF PERCUTANEOUS APPLICATION IN A 26-WEEK CARCINOGENICITY TEST IN CB6F1-TG rasH2 MICE
Induction of Drug Metabolism-Related Enzymes by Methylcholanthrene and Phenobarbital in Transgenic Mice Carrying Human Prototype c-Ha-ras Gene and Their Wild Type Littermates
21WA-03-3 In Vivo Toxicity of Aminophenylnorharman, a Product from the Reaction of Norharman and Aniline, in F344 Rats.
Use of IC tags in short-term carcinogenicity studies on CB6F1-TgrasH2 mice(Carcinogenicity, Proceedings of the 32nd Annual Meeting)
P8-31 Effect of vehicles for a dermal carcinogenicity testing of CB6F1-TgrasH2 mice(STATISTICAL AND TEST METHODS/LOCAL STIMURATION)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
P6-41 Comparative study on the carcinogenicity of phenolphthalein in rasH2 and p53 knockout mice(DRUG METABOLISM/CARCINOGENICITY)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
Influence of the administration route and the vehicle on CB6F1-TgrasH2 mice (CARCINOGENICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
Background data of human prototype c-Ha-ras transgenic (CB6Fl-TgrasH2) mice (CARCINOGENICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
Biological characteristics of gene-manipulated mice for carcinogenicity test (CARCINOGENICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
USE OF IC TAGS IN SHORT-TERM CARCINOGENICITY STUDY ON CB6F1 TGrasH2 MICE
Effects of in utero propylthiouracil exposure on the monoamine content of the rat fetus brain(Development, Reproduction, Proceedings of the 32nd Annual Meeting)
Effects of the p38 MAP kinase inhibitor SB203580 on the immune system of rats(Immune system, Allergy, Proceedings of the 32nd Annual Meeting)
Tissue distribution of rat plasma released enzymes(Blood, Proceedings of the 32nd Annual Meeting)
P-66 Effects of Tamoxlfen Treatment on the Uterus and Ovary In Rats.(Proceedings of the 27th Annual Meeting)
P-44 Some Consideration to the Significance of Serum Immunogiobulin Levels in the Immunotoxicy Testing(Proceedings of the 27th Annual Meeting)
22C-10-5 Differences in toxic changes between CB6F1-Tg-rasH2 mice and their nontransgenic littermates given cyclophosphamide by gavage weekly for 5 or 26 weeks (2) Immunotoxicity.
21D-03-1 Differences in toxic changes between CB6F1-Tg-rasH2 mice and their nontransgenic littermates given cyclophosphamide by gavage weekly for 5 or 26 weeks (1) General toxicity.
Collaborative work on evaluation of ovarian toxicity : 1) Effects of 2- or 4-week repeated-dose administration and fertility studies with medroxyprogesterone acetate in female rats
Calcitonin Induces Hypertrophy and Proliferation of Pars Intermedia Cells of the Rat Pituitary Gland
P-46 Differences in immunotoxic changes between CB6F1-Tg-rasH2 mice and their nontransgenic littermates given cyclophosphamide by gavage weekly for 5 weeks.(Proceedings of the 27th Annual Meeting)
Report 1 : TESTING FOR CARCINOGENICITY OF PHARMACEUTICALS : S1, A ; Conditions which require carcinogenicity studies for pharmaceuticals S1, B ; Use of two rodent species S1, C ; Dose selection for carcinogenicity studies of pharmaceuticals (CA
Carcinogenic comparative study on rasH2 mice produced by two breeding facilities
Spleen-Specific Development of Germinal Centers in Rats Treated with Antithyroid Drugs

もっと見る

スポンサーリンク